NCT04162210
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04162210
Title Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Acronym DREAMM-3
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | NLD | ITA | HUN | GRC | GBR | FRA | ESP | DEU | CAN | BRA | BGR | BEL | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Tucson Arizona 85715 United States Details
GSK Investigational Site Pueblo Colorado 81008 United States Details
GSK Investigational Site Detroit Michigan 48202 United States Details
GSK Investigational Site Albany New York 12208-3479 United States Details
GSK Investigational Site Clifton Park New York 12065 United States Details
GSK Investigational Site Cincinnati Ohio 45236 United States Details
GSK Investigational Site Corvallis Oregon 97301 United States Details
GSK Investigational Site Eugene Oregon 97401 United States Details
GSK Investigational Site Tyler Texas 75702 United States Details
GSK Investigational Site Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Gosford NSW New South Wales 2250 Australia Details
GSK Investigational Site Liverpool New South Wales 2170 Australia Details
GSK Investigational Site St Leonards New South Wales 2065 Australia Details
GSK Investigational Site Woodville South Australia 5011 Australia Details
GSK Investigational Site Hobart Tasmania 7000 Australia Details
GSK Investigational Site Clayton Victoria 3168 Australia Details
GSK Investigational Site Fitzroy Victoria 3065 Australia Details
GSK Investigational Site Geelong Victoria 3220 Australia Details
GSK Investigational Site Nedlands Western Australia 6009 Australia Details
GSK Investigational Site St Albans 03021 Australia Details
GSK Investigational Site Bruges 8000 Belgium Details
GSK Investigational Site Brussels 1090 Belgium Details
GSK Investigational Site Brussels 1200 Belgium Details
GSK Investigational Site Edegem 2650 Belgium Details
GSK Investigational Site Kortrijk 8500 Belgium Details
GSK Investigational Site Yvoir 5530 Belgium Details
GSK Investigational Site Porto Alegre Rio Grande do Sul 90035-903 Brazil Details
GSK Investigational Site Curitiba 80530-010 Brazil Details
GSK Investigational Site Fortaleza 60115-281 Brazil Details
GSK Investigational Site Porto Alegre 90110-270 Brazil Details
GSK Investigational Site Rio de Janeiro 22793-080 Brazil Details
GSK Investigational Site São Paulo 01321001 Brazil Details
GSK Investigational Site São Paulo 01509-900 Brazil Details
GSK Investigational Site São Paulo 04537-080 Brazil Details
GSK Investigational Site São Paulo 05651-901 Brazil Details
GSK Investigational Site Pleven 5800 Bulgaria Details
GSK Investigational Site Plovdiv 4000 Bulgaria Details
GSK Investigational Site Sofia 01431 Bulgaria Details
GSK Investigational Site Sofia 1000 Bulgaria Details
GSK Investigational Site Sofia 1407 Bulgaria Details
GSK Investigational Site Sofia 1606 Bulgaria Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Beijing 100000 China Details
GSK Investigational Site Beijing 100050 China Details
GSK Investigational Site Beijing 100191 China Details
GSK Investigational Site Beijing 100730 China Details
GSK Investigational Site Changsha 130012 China Details
GSK Investigational Site Chengdu 610041 China Details
GSK Investigational Site Guangzhou 510080 China Details
GSK Investigational Site Hangzhou 310009 China Details
GSK Investigational Site Nanchang 330006 China Details
GSK Investigational Site Shenzhen 518029 China Details
GSK Investigational Site Tianjin 300020 China Details
GSK Investigational Site Tianjin 300060 China Details
GSK Investigational Site Xuzhou 221006 China Details
GSK Investigational Site Zhengzhou 450052 China Details
GSK Investigational Site Le Mans 72015 France Details
GSK Investigational Site Montpellier 34295 France Details
GSK Investigational Site Poitiers 86021 France Details
GSK Investigational Site Berlin 13125 Germany Details
GSK Investigational Site Tübingen 72076 Germany Details
GSK Investigational Site Athens 10676 Greece Details
GSK Investigational Site Athens 115 28 Greece Details
GSK Investigational Site Haidari - Athens 12462 Greece Details
GSK Investigational Site Larissa 41 110 Greece Details
GSK Investigational Site Pátrai 26500 Greece Details
GSK Investigational Site Thessaloniki 54007 Greece Details
GSK Investigational Site Thessaloniki 57010 Greece Details
GSK Investigational Site Budapest 1083 Hungary Details
GSK Investigational Site Budapest 1088 Hungary Details
GSK Investigational Site Budapest 1097 Hungary Details
GSK Investigational Site Debrecen 4012 Hungary Details
GSK Investigational Site Kaposvár 7400 Hungary Details
GSK Investigational Site Nyíregyháza 4400 Hungary Details
GSK Investigational Site Bologna 40138 Italy Details
GSK Investigational Site Brescia 25123 Italy Details
GSK Investigational Site Catanzaro 88100 Italy Details
GSK Investigational Site Milan 20122 Italy Details
GSK Investigational Site Milan 20141 Italy Details
GSK Investigational Site Pavia 27100 Italy Details
GSK Investigational Site Perugia 05100 Italy Details
GSK Investigational Site Ravenna 48123 Italy Details
GSK Investigational Site Roma 00161 Italy Details
GSK Investigational Site San Giovanni Rotondo FG 71013 Italy Details
GSK Investigational Site Siena 53100 Italy Details
GSK Investigational Site Aichi 467-8602 Japan Details
GSK Investigational Site Chiba 277-8567 Japan Details
GSK Investigational Site Ehime 790-8524 Japan Details
GSK Investigational Site Fukushima 960-1295 Japan Details
GSK Investigational Site Gifu 503-8502 Japan Details
GSK Investigational Site Gunma 377-0280 Japan Details
GSK Investigational Site Hokkaido 060-8648 Japan Details
GSK Investigational Site Kyoto 602-8566 Japan Details
GSK Investigational Site Kyoto 603-8151 Japan Details
GSK Investigational Site Osaka 565-0871 Japan Details
GSK Investigational Site Tokyo 108-8639 Japan Details
GSK Investigational Site Tokyo 150-8935 Japan Details
GSK Investigational Site Amersfoort 3813 TZ Netherlands Details
GSK Investigational Site Gdansk 80-214 Poland Details
GSK Investigational Site Krakow 30510 Poland Details
GSK Investigational Site Torun 87-100 Poland Details
GSK Investigational Site Kaluga 248007 Russia Details
GSK Investigational Site Kirov 610027 Russia Details
GSK Investigational Site Krasnoyarsk 660022 Russia Details
GSK Investigational Site Nizhny Novgorod 603137 Russia Details
GSK Investigational Site Novosibirsk 630087 Russia Details
GSK Investigational Site Saint Petersburg 191024 Russia Details
GSK Investigational Site Saint Petersburg 197341 Russia Details
GSK Investigational Site Samara 443099 Russia Details
GSK Investigational Site Sochi 354057 Russia Details
GSK Investigational Site Syktyvkar 167904 Russia Details
GSK Investigational Site Tula 300053 Russia Details
GSK Investigational Site Yekaterinburg 620102 Russia Details
GSK Investigational Site Gyeonggi-do 10408 South Korea Details
GSK Investigational Site Hwasun 58128 South Korea Details
GSK Investigational Site Incheon 21565 South Korea Details
GSK Investigational Site Seongnam-si Gyeonggi-do 13620 South Korea Details
GSK Investigational Site Seoul 03080 South Korea Details
GSK Investigational Site Seoul 05505 South Korea Details
GSK Investigational Site Seoul 06591 South Korea Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Barcelona 08916 Spain Details
GSK Investigational Site L'Hospitalet de Llobrega 08908 Spain Details
GSK Investigational Site Málaga 29004 Spain Details
GSK Investigational Site PamplonaNavarra 31008 Spain Details
GSK Investigational Site Pozuelo de AlarcOn Madr 28223 Spain Details
GSK Investigational Site Santiago de Compostela 15706 Spain Details
GSK Investigational Site Airdrie ML6 0JS United Kingdom Details
GSK Investigational Site Dundee DD1 9SY United Kingdom Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site London EC1 7ED United Kingdom Details
GSK Investigational Site London W12 0NN United Kingdom Details
GSK Investigational Site Nottingham NG5 1PB United Kingdom Details
GSK Investigational Site Oxford OX3 7LJ United Kingdom Details
GSK Investigational Site Plymouth PL6 8D8 United Kingdom Details
GSK Investigational Site Stoke-on-Trent ST4 6QG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field